At the core of this innovation is a proprietary approach to botanical drug development. Using advanced biochemical processes, Pellamore enhances the potency and effectiveness of plant-based compounds while preserving their natural complexity. This allows for multiple mechanisms of action that address conditions at their source.
The company’s platform spans:
Over-the-counter transdermal therapeutics
Advanced dermatological treatments
Subdermal applications for conditions like arthritis and neuropathy
Guided by Harvard-trained biochemist Dr. Max Narovlyansky, Pellamore operates at the intersection of biotechnology and nature — building a new category of clinically grounded phytopharmaceuticals.
Pellamore is a pioneering phytopharmaceutical company redefining how medicine interacts with the body.
Rather than relying on systemic delivery — where drugs circulate throughout the entire body — Pellamore focuses on localized, transdermal therapies that deliver treatment directly to the site of need.